A maker of bioidentical hormone replacement therapy products, Biote Corp. trains and certifies doctors to implant tiny, grain-of-rice-sized hormone pellets under the skin, and supplies the kits, software, and marketing support their practices need. The company was founded in 2012 by OB/GYN Gary Donovitz, who turned to hormone therapy after seeing it transform a patient's life, and went public in 2022. Its name is a mashup of "bioidentical" and "testosterone."
Peterson Robert CharlesChief Financial Officer · 3 transactions
—
0as of Sep 2024
44.3K
—
44.3K
Haymaker Sponsor III LLC10% owner · 3 transactions
—
0†as of Jul 2022
7.94M
—
—
Select a row to see that insider’s individual transactions. † Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 5 years: +719.5K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.